• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about lymphoma

    Recent news which mentions lymphoma

    Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
    Tickers BMY IMTX
    Tags lymphoma Biotech Diseases
    From Benzinga
    Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus' Story
    Tags CAR T/cell Therapy Health & Healthcare NYSE:GILD
    From 3BL Media: Corporate Social Responsibility, Energy and Health News
    Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey
    Tags Gilead Health & Healthcare NYSE:GILD
    From 3BL Media: Corporate Social Responsibility, Energy and Health News
    Discover Cord Blood’s Life-Saving Benefits at the 7th Annual Arizona Cord Blood Conference – United by Our Strengths
    Tags Cancer Research be the match birthing process
    From PRUnderground
    Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
    Tickers FATE
    Tags Movers Biotech lymphoma
    From Benzinga
    Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
    Tickers GILD
    Tags Phase 2 Trial General lymphoma
    From Benzinga
    Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
    Tickers VIRX
    Tags General Phase 2 Trial VIRX
    From Benzinga
    Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
    Tickers JAZZ
    Tags News Health Care ASH21
    From Benzinga
    Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
    Tickers RHHBF RHHBY RHHVF
    Tags Market News ASH21 RHHBY
    From Benzinga
    Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
    Tickers GILD
    Tags ASH21 Market News GILD
    From Benzinga
    Bristol Myers Reveals Full Data For Breyanzi In Second-Line Lymphoma Setting
    Tickers BMY
    Tags General BMY Market News
    From Benzinga
    TG Therapeutics Shares Plunge After FDA Plans AdComm Meet For Blood Cancer Candidate
    Tickers TGTX
    Tags Benzinga Chronic Lymphocytic Leukemia lymphoma
    From Benzinga
    Affimed's Lymphoma Candidate Shows 100% Objective Response Rate At Highest Dose
    Tickers AFMD
    Tags AFMD Market News News
    From Benzinga
    Soligenix To File US Application For Its Lymphoma Photodynamic Therapy In 2H 2022
    Tickers SNGX
    Tags Penny Stocks Health Care SNGX
    From Benzinga
    IDI Consulting Supports the Leukemia & Lymphoma Society's Light The Night Walk
    Tags Leukemia Light The Night Pennsylvania
    From PRLog
    Gilead's Kite Files US Application To Expand Use Of Yescarta In Second-Line Setting
    Tickers GILD
    Tags News Briefs lymphoma
    From Benzinga
    BeiGene's Brukinsa Scores FDA Approval For Marginal Zone Lymphoma
    Tickers BGNE
    Tags BGNE Market News News
    From Benzinga
    Soligenix Stock Moves Higher On US Orphan Drug Tag For T-cell Lymphoma Candidate
    Tickers SNGX
    Tags Briefs Benzinga Movers
    From Benzinga
    ADC Therapeutics Announces $325M Financing Agreement With HealthCare Royalty
    Tickers ADCT
    Tags ADCT lymphoma Movers
    From Benzinga
    Fate Therapeutics' Stem Cell-Derived NK Lymphoma Candidate Casts Doubt Over Durability Of Response
    Tickers FATE
    Tags FATE General Biotech
    From Benzinga
    Cellectar Receives $2M NIH Grant For Rare Lymphoma Study
    Tickers CLRB
    Tags Phase 2 Clinical Trial General Financing
    From Benzinga
    F-star's FS118 Development Program To Include Checkpoint Naïve Cancer Patients
    Tickers FSTX
    Tags lymphoma Movers Biotech
    From Benzinga
    BeiGene's Brukinsa Scores Second Approval In Canada, This Time For Mantle Cell Lymphoma
    Tickers BGNE
    Tags Health Canada FDA General
    From Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.